Pro-Inflammatory Role of Platelets in Hypertension-Mediated End-Organ Damage Xiao-Jun DuHelen Kiriazis EDITORIAL 14 August 2013 Pages: 485 - 487
Acute Intravenous Infusion of an Adenosine Regulating Agent Improves Left Ventricular Function in Dogs with Advanced Heart Failure Mengjun WangRamesh C. GuptaHani N. Sabbah ORIGINAL ARTICLE 02 August 2013 Pages: 489 - 498
Docosahexaenoic Acid Supplementation Alters Key Properties of Cardiac Mitochondria and Modestly Attenuates Development of Left Ventricular Dysfunction in Pressure Overload-Induced Heart Failure Erinne R. DabkowskiKelly A. O’ConnellWilliam C. Stanley ORIGINAL ARTICLE 07 September 2013 Pages: 499 - 510
Mechanistic Studies of AVE3085 Against Homocysteine in Endothelial Protection Qin YangHong-Mei XueCheuk-Man Yu ORIGINAL ARTICLE 12 July 2013 Pages: 511 - 520
Inhibition of Platelet Activation by Clopidogrel Prevents Hypertension-Induced Cardiac Inflammation and Fibrosis Li-Xin JiaGuan-Ming QiJie Du ORIGINAL ARTICLE Open access 26 July 2013 Pages: 521 - 530
Anti-Atherogenic Effects of Methotrexate Carried by a Lipid Nanoemulsion That Binds to LDL Receptors in Cholesterol-fed Rabbits Adriana BulgarelliAntonio C. A. Leite JrRaul C. Maranhão ORIGINAL ARTICLE 25 September 2013 Pages: 531 - 539
Enhanced NO Signaling in Patients with Takotsubo Cardiomyopathy: Short-Term Pain, Long-Term Gain? Thanh H. NguyenChristopher J. NeilJohn D. Horowitz ORIGINAL ARTICLE 07 August 2013 Pages: 541 - 547
Aspirin Dose Increase from 75 to 150 mg Suppresses Red Blood Cell Contribution to Suboptimal Platelet Response to Aspirin in Patients with CAD Kamil KarolczakRobert PietruszynskiCezary Watala ORIGINAL ARTICLE 21 August 2013 Pages: 549 - 558
New Therapies Targeting apoB Metabolism for High-Risk Patients with Inherited Dyslipidaemias: What Can the Clinician Expect? Amirhossein SahebkarGerald F. Watts REVIEW ARTICLE 03 August 2013 Pages: 559 - 567
Exercise-induced Myalgia may Limit the Cardiovascular Benefits of Statins Lionel H. Opie REVIEW ARTICLE 10 August 2013 Pages: 569 - 572
Rationale and Design of a Randomized, Double-Blind, Placebo Controlled Multicenter Trial to Study Efficacy, Security, and Long Term Effects of Intermittent Repeated Levosimendan Administration in Patients with Advanced Heart Failure: LAICA study Martín J. García-GonzálezManuel de Mora-Martínon behalf of the LAICA study investigators ORIGINAL ARTICLE Open access 27 July 2013 Pages: 573 - 579
Renal Effects of Levosimendan: A Consensus Report Mehmet B. YilmazElena GrossiniGerhard Wikström REVIEW ARTICLE Open access 09 August 2013 Pages: 581 - 590
